Federal award
VEREIN ZUR PRAEVENTION UND THERAPIE BOESARTIGER ERKRANKUNGEN, AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP
W81XWH1910783
Assistance
Obligated and Ceiling
- Obligated (net)
- $5,232,648.00
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $5,962,834.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- VEREIN ZUR PRAEVENTION UND THERAPIE BOESARTIGER ERKRANKUNGEN, AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP · X182EYK34L47
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MEDIZINISCHE UNIVERSITÄT WIEN · EJCLLTK1LSN4
- Awarding agency
- Department of Defense · sub-agency 97DH · office HT9425
- Funding agency
- Department of Defense · sub-agency 97DH
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH1910783
- Award type code
- 04
- Actions
- 7 · Sep 11, 2019 to Sep 10, 2026
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 10, 2026 | FY2026 | P00006 | B1 | $0.00 | — |
| Apr 17, 2025 | FY2025 | P00005 | B1 | −$703,904.39 | — |
| Jul 21, 2024 | FY2024 | P00004 | B1 | $0.00 | — |
| Sep 28, 2023 | FY2023 | P00003 | B1 | −$26,281.61 | — |
| Oct 30, 2020 | FY2021 | P00002 | B1 | $0.00 | — |
| Feb 26, 2020 | FY2020 | P00001 | EX | $0.00 | — |
| Sep 11, 2019 | FY2019 | 0 | A1 | $5,962,834.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.